Get started
Author

Erica K. Anderson

Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia
2020 · Geoffrey L. Uy, Ibrahim Aldoss, et al. · Blood · 341
PDF
Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6
2018 · William McCoull, Tony Cheung, et al. · ACS Chemical Biology · 141
PDF
Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors
2017 · William McCoull, Roman D. Abrams, et al. · Journal of Medicinal Chemistry · 83
Concurrent Generation of Functional Smooth Muscle and Endothelial Cells via a Vascular Progenitor
2013 · Melanie Marchand, Erica K. Anderson, et al. · Stem Cells Translational Medicine · 45
PDF
Covalent binding of the organophosphorus agent FP-biotin to tyrosine in eight proteins that have no active site serine
2009 · Hasmik Grigoryan, Bin Li, et al. · Chemico-Biological Interactions · 40
Discovery and Optimization of a Novel Series of Highly Selective JAK1 Kinase Inhibitors
2018 · Neil P. Grimster, Erica Anderson, et al. · Journal of Medicinal Chemistry · 27
Ex Vivo Drug Sensitivity Correlates with Clinical Response and Supports Personalized Therapy in Pediatric AML
2022 · Debbie C. Strachan, Christine J. Gu, et al. · Cancers · 11
PDF
Abstract 979: Discovery of the JAK1 selective kinase inhibitor AZD4205
2017 · Jason G. Kettle, Qibin Su, et al. · Cancer Research · 5
Tretinoin Enhances the Effects of Chemotherapy in Juvenile Myelomonocytic Leukemia Using an Ex Vivo Drug Sensitivity Assay
2023 · Elliot Stieglitz, Christine J. Gu, et al. · JCO Precision Oncology · 4
Abstract 4046: Targeting jak/stat adaptive mechanism with jak1 inhibitor azd4205 reduces residual disease and prolongs benefit of osimertinib
2017 · Huawei (Ray) Chen, Geraldine Bebernitz, et al. · Cancer Research · 3
Correlation of ex vivo drug sensitivity with clinical response in pediatric AML.
2021 · Ryosuke Kita, Michelle A. Richardson, et al. · Journal of Clinical Oncology · 2
Development of a multiomics and functional drug sensitivity platform to investigate cell type specific drug effects in AML.
2021 · Marianne T. Santaguida, Ryosuke Kita, et al. · Journal of Clinical Oncology · 1
Abstract 4937: Comparison of orthotopic and subcutaneous implantation of pancreatic cancer patient-derived xenograft models for drug development
2017 · Sarah L. Fong, Marybeth A. Pysz, et al. · Cancer Research · 1
Ex Vivo Drug Sensitivity Assay Correlates with Clinical Response and Identifies Panobinostat and Bortezomib As a Potential Novel Drug Combination for Pediatric AML
2021 · Debbie C Strachan, Christine Gu, et al. · Blood
Prediction of Clinical Response to Venetoclax Plus Decitabine in AML Using a 7-Day Ex Vivo Assay
2021 · Markus D Lacher, Michelle A Richardson, et al. · Blood
Works count: 15
Citation count: 704
H-index: 7
I10-index: 7
Year
Topic
Type